Record number of first-time observers get Hubble telescope time
Since NASA introduced a double-blind review system to reduce bias, more successful proposals are coming from astronomers who haven’t been awarded observation time before.
A new ankylosaurid from the Upper Cretaceous Nemegt Formation of Mongolia and implications for paleoecology of armoured dinosaurs
Scientific Reports – A new ankylosaurid from the Upper Cretaceous…
A new mathematical modeling approach for thermal exploration efficiency under different geothermal well layout conditions
Scientific Reports – A new mathematical modeling approach for…
Assessing population exposure to coastal flooding due to sea level rise
The exposure of populations to sea-level rise is a leading indicator assessing the impact of future climate change on coastal regions. The authors identify three spatial zones of flooding such as mean…
Senior Researcher (Tuomanen Lab)
Two (2) years of relevant, post-degree work experience is required. No experience is required with a Master’s degree. COVID-19 vaccine: As of September 10, 2021, St. Jude Children’s Research Hospital…
China material stocks and flows account for 1978–2018
Measurement(s) Material stocks • Material flows Technology Type(s) digital curation • Mathematical Model Sample Characteristic – Location China Machine-accessible metadata file describing the reported…
AI In Drug Discovery Market To Cross Valuation Of US$ 10.93 Bn By 2031: Transparency Market Research
AI in Drug Discovery Market: Introduction
According to the report, the global AI in drug discovery market was valued at US$ 0.35 Bn in 2020 and is projected to expand at a CAGR of 36.1% from 2021 to 2031. Artificial intelligence
Taking a leave of absence, Ampio Pharmaceuticals CEO passes baton to a new board member; Axel Hoos’ cancer biotech lands a CFO
Before you dive into your Thanksgiving feasts, Peer Review has some appointments to share: → Mike Macaluso will be taking a one-year medical leave of absence from his duties as chairman and CEO of…
FDA asks court for 55 years to complete a FOIA request on the Pfizer/BioNTech vaccine
A nonprofit dedicated to transparency is calling on the FDA to release any and all documentation related to the approval of the Pfizer/BioNTech Covid-19 vaccine. And while FOIA requests are notorious…
UPDATED: Merck’s pause on an HIV program snowballs as a Gilead-partnered trial is shoved into limbo
Merck’s announcement last week that an experimental HIV combo therapy resulted in a drop in immune cell counts, and its subsequent decision to halt a Phase II study, is starting to see a snowball…